Gamma-Hydroxybutyrate (GHB): A Scoping Review of Pharmacology, Toxicology, Motives for Use, and User Groups

REFERENCES

• Abanades, S.; Farre, M.; Barral, D.; Torrens, M.; Closas, N.; Langohr, K.; Pastor, A. & de la Torre, R. 2007. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users. Journal of Clinical Psychopharmacology 27: 625–38.
   PubMed Web of Science ®Google Scholar
• Amato, L.; Minozzi, S. & Davoli, M. 2011. Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome. Cochrane Database of Systematic Reviews 15 (6): CD008537.
   Google Scholar
• Anderson, I.B.; Kim, S.Y.; Dyer, J.E.; Burkhardt, C.B.; Iknoian, J.C.; Walsh, M.J. & Blanc, P.D. 2006. Trends in γ-hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003. Annals of Emergency Medicine 47 (2): 177–83.
   PubMed Web of Science ®Google Scholar
• Andresen, H.; Stimpfl, T.; Sprys, N.; Schnitgerhans, T. & Müller, A. 2008. Liquid Ecstasy: A significant drug problem. Deutsches Ärzteblatt International 105 (36): 599–603.
   PubMed Web of Science ®Google Scholar
• Andriamampandry, C.; Taleb, O.; Viry, S.; Muller, C.; Humbert, J.P.; Gobaille, S.; Aunis, D. & Maitre, M. 2003. Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator gamma-hydroxybutyrate (GHB). FASEB Journal 17 (12): 1691–93.
   Google Scholar
• Antman, E.; Lau, J.; Kupeinick, B.; Mosteller, F. & Chalmers, T. 1992. A comparison of results of meta-analysis of RCTs and recommendations of clinical experts. Journal of American MedicalAssociation 268: 240–248.
   PubMed Web of Science ®Google Scholar
• Arksey, H. & O’Malley, L. 2005. Scoping studies: Towards a methodological framework. International Journal of Social Research Methodology 8 (1): 19–32.
   Google Scholar
• Aromatario, M.; Bottoni, E.; Santoni, M. & Ciallella, C. 2012. New ‘‘lethal highs’’: A case of a deadly cocktail of GHB and Mephedrone. Forensic Science International 223: 38–41.
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare (AIHW). 2005. National Drug Strategy Household Survey 2004. Canberra, ACT: Australian Institute of Health and Welfare.
   Google Scholar
• Barker, J.C.; Harris, S.L. & Dyer, J.E. 2007. Experiences of gamma hydroxybutyrate (GHB) ingestion: A focus group study. Journal of Psychoactive Drugs 39 (2): 115–29.
   PubMed Web of Science ®Google Scholar
• Beránková, K.; Mutnănská, K. & Balíkova, M. 2006. Gamma-hydroxybutyric acid stability and formation in blood and urine. Forensic Science International 161: 158–162.
   PubMed Web of Science ®Google Scholar
• Bhattacharya, I. & Boje, K.M.K. 2004. g-Hydroxybutyrate (GHB) carrier mediated transport across the blood brain barrier. Journal of Pharmacology and Experimental Therapeutics 331: 92–8.
   Web of Science ®Google Scholar
• Brenneisen, R.; ElSohly, M.A.; Murphy, T.P.; Passarelli, J.; Russmann, S.; Sala-mone, S.J. & Watson, D.E. 2004. Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects. Journal of Analytical Toxicology 28: 625–30.
   PubMed Web of Science ®Google Scholar
• British Crime Survey (BCS). 2011. Drug Misuse Declared: Findings from the 2010/2011 British Crime Survey. Available at: http://www.homeoffice.gov.uk/publications/science-research-statistics/research-statistics/crime-research/hosb1211/hosb1211?view=Binary.
   Google Scholar
• Britt-Covell, G. & McCance-Katz, E.F. 2005. A brief overview of the clinical pharmacology of “club drugs.” Substance Use & Misuse 40: 1189–201.
   PubMed Web of Science ®Google Scholar
• Brown, P.C.; Alfonso, J. & Dunn, M.E. 2011. Gamma hydroxybutyrate use: Exploring the influence of outcome expectancies through memory modeling. The American Journal on Addictions 20: 127–36.
   PubMed Web of Science ®Google Scholar
• Brunt, T.M.; Koeterb, M.W.; Hertoghsa, N.; van Noorden, M.S. & van den Brink, W. 2013. Socio-demographic and substance use characteristics of gamma hydroxybutyrate (GHB) dependent inpatients and associations with dependence severity. Drug and Alcohol Dependence 131 (3): 316–19.
   PubMed Web of Science ®Google Scholar
• Camacho, A.; Matthews, S.C. & Dimsdale, J.E. 2004. Use of GHB compounds by HIV-positive individuals. The American Journal on Addictions 13 (2): 120–7.
   PubMed Web of Science ®Google Scholar
• Camacho, A.; Matthews, S.C.; Murray, C.F. & Dimsdale, J.E. 2005. Use of GHB compounds among college students. The American Journal of Drugs and Alcohol Abuse 31 (4): 601–07.
   PubMed Web of Science ®Google Scholar
• Caputo, F.; Vignoli, T.; Maremmani, I.; Bernardi, M. & Zoli, G. 2009. Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: A review. International Journal of Environmental Research & Medicine 6: 1917–29.
   Web of Science ®Google Scholar
• Carai, M.A.; Colombo, G,; Brunetti, G.; Melis, S.; Serra, S.; Vacca, G.; Mastinu, S.; Pistuddi, A.M.; Solinas, C. & Cignarella, G. 2001. Role of GABAB receptors in the sedative/hypnotic effect of γ-hydroxybutyric acid. European Journal of Pharmacology 428: 315–321.
   PubMed Web of Science ®Google Scholar
• Daudt, H.M.; van Mossel, C. & Scott, S. 2013. Enhancing the scoping study methodology: A large, inter-professional team’s experience with Arksey and O’Malley’s framework. BMC Medical Research Methodology 13: 48.
   PubMed Web of Science ®Google Scholar
• Degenhardt, L.; Darke, S. & Dillon, P. 2002. GHB use among Australians: Characteristics, use patterns, and associated harm. Drug and Alcohol Dependence 67: 89–94.
   PubMed Web of Science ®Google Scholar
• Degenhardt, L.; Darke, S. & Dillon, P. 2003. The prevalence and correlates of gammahydroxybutyrate (GHB) overdose among Australian users. Journal of Addiction 98: 199–204.
   PubMed Web of Science ®Google Scholar
• Degenhardt, L. & Dunn, M. 2008. The epidemiology of GHB and ketamine use in an Australian household survey. International Journal of Drug Policy 19: 311–16.
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 2008. Thematic Papers—GHB and its Precursor GBL: An Emerging Trend Case Study. Lisbon: EMCDDA.
   Google Scholar
• ———. 2011. European Information Centre and Database on New Drugs: 2012 Annual Report. Lisbon: EMCDDA.
   Google Scholar
• Fendrich, M.; Wislar, J.S.; Johnson, T.P. & Hubbell, A. 2003. A contextual profile of club drug use among adults in Chicago. Journal of Addiction 98: 1693–1703.
   PubMed Web of Science ®Google Scholar
• Galicia, M.; Nogue, S. & Miró, O. 2011. Liquid ecstasy intoxication: Clinical features of 505 consecutive emergency department patients. Emergency Medicine Journal 28: 462–6.
   PubMed Web of Science ®Google Scholar
• Galloway, G. P.; Frederick-Osborne, S.L.; Staggers, F.E. Jr.; Gonzales, M.; Stalcup, S.A. & Smith, D.E. 1997. Gamma-hydroxybutyrate: An emerging drug of abuse that causes physical dependency. Journal of Addiction 92: 89–96.
   PubMed Web of Science ®Google Scholar
• Gordon, S.M.; Forman, R.F. & Siatkowski, C. 2006. Knowledge and use of the Internet as a source of controlled substances. Journal of Substance Abuse Treatment 30: 271–4.
   PubMed Web of Science ®Google Scholar
• Green, S. & Higgins, J. 2005. “Glossary.” In: Cochrane Handbook for Systematic Reviews of Interventions 4.2.5, The Cochrane Collaboration. Available at: http://www.cochrane.org/resources/glossary.htm. Accessed October 19, 2012.
   Google Scholar
• Halkitis, P.N.; Green, K.A. & Mourgues, P. 2005. Longitudinal investigation of methamphetamine use among gay and bisexual men in New York City: Findings from Project BUMPS. Journal of Urban Health 81 (1): 8–25.
   Google Scholar
• Halkitis, P.N. & Palamar, J.J. 2006. GHB use among gay and bisexual men. Addictive Behaviours 31 (11): 2135–9.
   PubMed Web of Science ®Google Scholar
• Hensley, L. 2003. GHB abuse trends and use in drug-facilitated sexual assault: Implications for prevention. National Association of Student Personnel Administrators 40: 17–28.
   Google Scholar
• Horyniak, D.; Degenhardt, L.; Smit, D.V.; Munir, V.; Johnston, J.; Fry, C. & Dietze, P. 2013. Pattern and characteristics of ecstasy and related drug (ERD) presentations at two hospital emergency departments, Melbourne, Australia, 2008. Emergency Medicine Journal 31 (4): 317–22.
   PubMed Web of Science ®Google Scholar
• Kam, P.C. & Yoong, F.F. 1998. Gamma-hydroxybutyric acid: An emerging recreational drug. Anaesthesia 53: 1195–98.
   PubMed Web of Science ®Google Scholar
• Kueh, D.; Iwamoto, K.; Poling, A. & Baker, L.E. 2008. Effects of gamma-hydroxybutyrate (GHB) and its metabolic precursors on delayed-matching-to-position performance in rats. Pharmacology, Biochemistry and Behaviour 89: 179–87.
   PubMed Web of Science ®Google Scholar
• Laborit, H. 1964. Sodium 4-hydroxybutyrate. International Journal of Neuropharmacology 3: 433–52.
   PubMedGoogle Scholar
• Lenz, D.; Rothschild, M.A. & Kroner, L. 2008. Intoxications due to ingestion of gammabutyrolactone: Organ distribution of gamma-hydroxybutyric acid and gamma-butyrolactone. Therapeutic Drug Monitoring 30: 755–61.
   PubMed Web of Science ®Google Scholar
• Lettieri, J.T. & Fung, H.L. 1979. Dose-dependent pharmacokinetics and hypnotic effects of sodium g-hydroxybutyrate in the rat. Journal of Pharmacology and Experimental Therapeutics 208: 7–11.
   PubMed Web of Science ®Google Scholar
• Levac, D.; Colquhoun, H. & O’Brien, K.K. 2010. Scoping studies: Advancing the methodology. Implementation Science 5: 69.
   PubMed Web of Science ®Google Scholar
• Liechti, M.E.; Kunz, I.; Greminger, P.; Speich, R. & Kupferschmidt, H. 2006. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use. Drug and Alcohol Dependence 81: 323–26.
   PubMed Web of Science ®Google Scholar
• Madea, B. & Mubhoff, F. 2009. Knock-out drugs: Their prevalence, modes of action, and means of detection. Deutsches Ärzteblatt International 106 (20): 341–7.
   PubMed Web of Science ®Google Scholar
• Mamelak, M. 1989. Gamma-hydroxybutyrate: An endogenous regulator of energy metabolism. Neuroscience & Biobehavioural Reviews 13: 187–98.
   PubMed Web of Science ®Google Scholar
• Mamelak, M. 2009. Narcolepsy and depression and the neurobiology of gammahydroxybutyrate. Progress in Neurobiology 89: 193–219.
   PubMed Web of Science ®Google Scholar
• Maremmani, I.; La Manna, F. & Tagliamone, A. 2001. Long-term therapy using GHB (sodium gamma hydroxybutyrate) for treatment-resistant chronic alcoholics. Journal of Psychoactive Drugs 33: 135–142.
   Google Scholar
• Marinetti, L.J.; Isenschmid, D.S.; Hepler, B.R. & Kanluen, S. 2005. Analysis of GHB and 4-methyl-GHB in postmortem matrices after long-term storage. Journals of Analytical Toxicology 29: 41–7.
   PubMed Web of Science ®Google Scholar
• Marwick, C. 1997. Coma-inducing drug GHB may be reclassified. The Journal of the American Medical Association 277: 1505–11.
   PubMed Web of Science ®Google Scholar
• Mason, P.E. & Kerns, W.P. 2002. Gamma hydroxybutyric acid (GHB) intoxication. Academic Emergency Medicine 9 (7): 730–39.
   PubMed Web of Science ®Google Scholar
• Mattison, A.M.; Ross, M.W.; Wolfson, T.; Franklin, D. & San Diego HIV Neurobehavioral Research Center Group. 2001. Circuit party attendance, club drug use, and unsafe sex in gay men. Journal of Substance Abuse 13 (1–2): 119–26.
   PubMedGoogle Scholar
• Mays, N.; Roberts, E. & Popay, J. 2001. Synthesising research evidence. In N. Fulop, P. Allen, A. Clarke, & N. Black ( Eds.) Studying the Organisation and Delivery of Health Services: Research Methods. London: Routledge.
   Google Scholar
• McCabe, E.R.; Layne, E.C.; Slusher, N. & Bessman, S.P. 1971. Synergy of ethanol and a natural soporific-gamma hydroxybutyrate. Science 171: 404–6.
   PubMed Web of Science ®Google Scholar
• McDonough, M.; Kennedy, N.; Glasper, A. & Bearn, J. 2004. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: A review. Drug and Alcohol Dependence 75: 3–9.
   PubMed Web of Science ®Google Scholar
• Miotto, K.; Darakjian, J.; Basch, J.; Murray, S.; Zogg, J. & Rawson, R. 2001. Gamma-hydroxybutyric acid: Patterns of use, effects and withdrawal. The American Journal on Addictions 10: 232–41.
   PubMed Web of Science ®Google Scholar
• Miró, O.; Nogúe, S.; Espinosa, G.; To-Figueras, J. & Sánchez, M. 2002. Trends in illicit drug emergencies: The emerging role of gammahydroxybutyrate. Journal of Toxicology–Clinical Toxicology 40: 129–35.
   PubMed Web of Science ®Google Scholar
• Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G. & The PRISMA Group. 2009. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. Open Medicine 3: 123–30.
   PubMedGoogle Scholar
• Morris, M.E.; Morse, B.L.; Baciewicz, G.J.; Tessena, M.M.; Acquisto, N.M.; Hutchinson, D.J. & DiCenzo, R. 2011. Monocarboxylate transporter inhibition with osmotic diuresis increases γ-hydroxybutyrate renal elimination in humans: A proof-of-concept study. Journal of Clinical Toxicology 1: 105.
   Google Scholar
• Morse, B.L. & Morris, M.E. 2013. Effects of monocarboxylate transporter inhibition on the oral toxicokinetics/toxicodynamics of γ-hydroxybutyrate and γ-butyrolactone. Journal of Pharmacology and Experimental Therapeutics 345 (1): 102–10.
   PubMed Web of Science ®Google Scholar
• Morse, B.L.; Vijay, N. & Morri, M. 2012. γ-hydroxybutyrate (GHB)-induced respiratory depression: Combined receptor-transporter inhibition therapy for treatment in GHB overdose. Molecular Pharmacology 82 (2): 226–235.
   PubMed Web of Science ®Google Scholar
• Murray-Bennett, W.R.; Wilson, L.G. & Roy-Byrne, P.P. 2007. Gamma-hydroxybutyric acid (GHB) withdrawal: A case report. Journal of Psychoactive Drugs 39 (3): 293–6.
   PubMed Web of Science ®Google Scholar
• National Institute on Drug Abuse (NIDA). 2003. NIDA Community Drug Alert Bulletin-Club Drugs. Available at: http://www.drugabuse.gov/clubalert/clubdrugalert.html. Accessed May 1, 2013.
   Google Scholar
• Nicholson, K.L. & Balster, R.L. 2001. GHB: A new and novel drug of abuse. Drug and Alcohol Dependence 63: 1–22.
   PubMed Web of Science ®Google Scholar
• O’Connell, T.; Kaye, L. & Plosay, J.J. 2000. Gamma-hydroxybutyrate (GHB): A newer drug of abuse. American Family Physician 62 (11): 2478–83.
   PubMed Web of Science ®Google Scholar
• Ostrow, D.G. 2000. The role of drugs in the sexual lives of men who have sex with men: Continuing barriers to researching this question. AIDS and Behavior 4: 205–19.
   Google Scholar
• Palamar, J.J. & Halkitis, P.N. 2006. A qualitative analysis of GHB use among gay men: Reasons for use despite potential adverse outcomes. International Journal of Drug Policy 17 (1): 23–8.
   PubMed Web of Science ®Google Scholar
• Pawson, R. 2002. Evidence-based policy: In search of a method. Evaluation 8: 157–181.
   Google Scholar
• Pedraza, C.; Garciá, F.B. & Navarro, J.F. 2009. Neurotoxic effects induced by gammahydroxybutyric acid (GHB) in male rats. International Journal of Neuropsychopharmacology 12: 1165–77.
   PubMed Web of Science ®Google Scholar
• Perez, E.; Chu, J. & Bania, T. 2006. Seven days of gamma-hydroxybutyrate (GHB) use produces severe withdrawal. Annals of Emergency Medicine 48: 219–20.
   PubMed Web of Science ®Google Scholar
• Pittman, H.J. 2002. What you need to know about GHB. Nursing, 32 (11): 32cc6–32cc7.
   Google Scholar
• Quang, L.S.; Colombo, G.; Lobina, C.; Maccioni, P.; Orru, A.; Gessa, G.L.; Maher, T.J. & Cara, M.A. 2006. Evaluation for the withdrawal syndrome from hydroxybutyric acid (GHB), butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines. Annals of the New York Academy of Sciences 1074: 545–58.
   PubMed Web of Science ®Google Scholar
• Ritchie, J. & Spencer, L. 1994. Qualitative data analysis for applied policy research. In: A. Bryman & R.G. Burgess ( Eds.) Analysing Qualitative Data. London: Routledge.
   Google Scholar
• Roiko, S.A.; Vijay, N.; Felmlee, M.A. & Morris, M.E. 2013. Brain extracellular γ-hydroxybutyrate concentrations are decreased by L-lactate in rats: Role in the treatment of overdoses. Pharmaceutical Research 30 (5): 1338–48.
   PubMed Web of Science ®Google Scholar
• Rossi, R.; Lancia, M.; Gambelunghe, C.; Oliva, A. & Fucci, N. 2009. Identification of GHB and morphine in hair in a case of drug-facilitated sexual assault. Forensic Science International 186: 9–11.
   Web of Science ®Google Scholar
• Scholey, A.B.; Parrott, A.C.; Buchanan, T.; Heffernan, T.M.; Ling, J. & Rodgers, J. 2004. Increased intensity of ecstasy and polydrug usage in the more experienced recreational ecstasy/MDMA users: A WWW study. Addictive Behaviours 29: 743–52.
   PubMed Web of Science ®Google Scholar
• Sircar, R. & Basak, A. 2004. Adolescent gamma-hydroxybutyric acid exposure decreases cortical N-methyl-d-aspartate receptor and impairs spatial learning. Pharmacology, Biochemistry and Behaviour 79: 701–8.
   PubMed Web of Science ®Google Scholar
• Smalley, S. 2003. The perfect crime. Newsweek 141 (5): 52.
   PubMedGoogle Scholar
• Smith, K.M.; Larive, L.L. & Romanelli, F. 2002. Club drugs: Methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and γ-hydroxybutyrate. American Journal of Health System Pharmacy 59: 1067–76.
   PubMed Web of Science ®Google Scholar
• Snead, O.C. & Gibson, K.M. 2005. Drug therapy: (Gamma)-hydroxybutyric acid. The New England Journal of Medicine 352: 2721–32.
   PubMed Web of Science ®Google Scholar
• Stella, L.; Addolorato, G.; Rinaldi, B.; Capuano, A.; Berrino, L.; Rossi, F. & Maionea, S. 2008. An open randomized study of the treatment of escitalopram alone and combined with hydroxybutyric acid and naltrexone in alcoholic patients. Pharmacological Research 57 (4): 312–17.
   PubMed Web of Science ®Google Scholar
• Sumnall, H.R.; Wagstaff, G.F. & Cole, J.C. 2004. Self-reported psychopathology in polydrug users. Journal of Psychopharmacology 18: 63–69.
   Web of Science ®Google Scholar
• Sumnall, H.R.; Woolfall, K.; Edwards, S.; Cole, J.C. & Beynon, C.M. 2008. Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB). Drug and Alcohol Dependence 92: 286–90.
   PubMed Web of Science ®Google Scholar
• Tarabar, A.F. & Nelson, L.S. 2004. The gamma-hydroxybutyrate withdrawal syndrome. Toxicological Reviews 23: 45–9.
   PubMedGoogle Scholar
• Ting Wong, G.C.; Gibson, M.K. & Snead, C.O. 2004. From the street to the brain: Neurobiology of the recreational drug, g- hydroxybutyric acid. Trends in Pharmacological Sciences 25 (1): 29–34.
   PubMed Web of Science ®Google Scholar
• Van Amsterdam, J.G.C.; Brunt, T.M.; McMaster, T.B. & Niesink, R.J.M. 2012. Possible long-term effects of -hydroxybutyric acid (GHB) due to neurotoxicity and overdose. Neuroscience and Biobehavioral Reviews 36: 1217–27.
   PubMed Web of Science ®Google Scholar
• Van Amsterdam, J.G.C.; Van Laar, M.; Brunt, T.M. & Van Den Brink, W. 2011. Risk assessment of gamma-hydroxybutyric acid (GHB) in the Netherlands. Regulatory Toxicology and Pharmacology 63: 55–63.
   Web of Science ®Google Scholar
• Van Hout, M.C. & Bingham, T. 2013. “Silk Road,” The virtual drug marketplace: A single case study of user experiences. International Journal of Drug Policy 24 (5): 385–91.
   Web of Science ®Google Scholar
• Van Laar, M.; Cruts, A.A.; Van Ooyen-Houben, M.M.; Meyr, R.F.; Croes, E. & Brunt, T. 2011. Netherlands National Drug Monitor: NDM Annual Report 2010. Utrecht, The Netherlands: NDM.
   Google Scholar
• Van Noorden, M.S.; Van Dongen, L.C.A.M.; Zitman, F.G. & Vergouwen, M.D. 2009. Gamma-hydroxybutyrate withdrawal syndrome: Dangerous but not well-known. General Hospital Psychiatry 31: 394–6.
   PubMed Web of Science ®Google Scholar
• Van Noorden, M.S.; Kamal, R.; de Jong, C.A.; Vergouwen, A.C. & Zitman, F.G. 2010. Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: Diagnosis and treatment. Ned. Tijdschr. Geneeskd. 154: 1286.
   Google Scholar
• Van Rooij, A.J.; Schoenmakers, T.M. & Van de Mheen, D. 2011. Nationaal Prevalentie Onderzoek Middelengebruik 2009: Kerncijfers 2009. Rotterdam: IVO.
   Google Scholar
• Van Sassenbroeck, D.K.; De, N.N.; De, P.P.; Belpaire, F.M.; Verstraete, A.G.; Calle, P.A. & Buylaert, W.A. 2007. Abrupt awakening phenomenon associated with gammahydroxybutyrate use: A case series. Clinical Toxicology 45: 533–8.
   PubMed Web of Science ®Google Scholar
• Varela, M.; Nogue, S. & Oros, M. 2004. Gamma hydroxybutyrate use for sexual assault. Emergency Medical Journal 21: 255–6.
   PubMed Web of Science ®Google Scholar
• Vijay, N. & Morris, M.E. 2013. Role of monocarboxylate transporters in drug delivery to the brain. Current Pharmaceutical Design 20 (10): 1487–98.
   Google Scholar
• Winstock, A.R.; Griffiths, P. & Stewart, D. 2001. Drugs and the dance music scene: A survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug and Alcohol Dependence 64: 9–17.
   PubMed Web of Science ®Google Scholar
• Wojtowica, J.M.; Yarema, M.C. & Wax, P.M. 2008. Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: A case report and systematic review. Canadian Journal of Emergency Medicine 10 (1): 69–74.
   Web of Science ®Google Scholar
• Wolf, M. 2007. GHB and analogues: High-Risk club drugs. New York: Rosen Publishing.
   Google Scholar
• Wood, D.M.; Brailsford, A.D. & Dargan, P.I. 2011. Acute toxicity and withdrawal syndromes related to gamma-hydroxybutyrate (GHB) and its analogues gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD). Drug Testing & Analysis 3: 417–25.
   PubMed Web of Science ®Google Scholar
• Wood, D.M.; Greene, S.L. & Dargan, P.I. 2013 Five-year trends in self-reported recreational drugs associated with presentation to a UK emergency department with suspected drug-related toxicity. European Journal of Emergency Medicine 20 (4): 263–7.
   PubMed Web of Science ®Google Scholar
• World Health Organisation (WHO). 2012. Gamma-hydroxybutyric acid (GHB) Critical Review Report, Expert Committee on Drug Dependence, WHO Thirty-fifth Meeting, Hammamet, Tunisia, June 4-8, 2012.
   Google Scholar
• Yacoubian, G.S.; Miller, S. & Pianim, S. 2004. Toward an ecstasy and other club drug (EOCD) prevention intervention for rave attendees. Journal of Drug Education 34: 41–59.
   PubMed Web of Science ®Google Scholar
• Zvosec, D.L.; Smith, S.W. & Hall, B.J. 2009. Three deaths associated with use of Xyrem. Sleep Medicine 10: 490–93.
   PubMed Web of Science ®Google Scholar
• Zvosec, D.L.; Smith, S.W.; Porrata, T.; Strobl, A.Q. & Dyer, J.E. 2007. Gamma hydroxybutyrate (GHB)-associated fatalities: Overlap of postmortem GHB levels with endogenous, therapeutic, and nonfatal GHB toxicity cases and factors supporting exogenous origin, Annual Meeting of the National Association of Medical Examiners, Savannah, GA, October 13, 2007.
   Google Scholar
• Zvosec, D.L; Smith, S.W; Porrata, T; Strobl, A.Q. & Dyer, J.E. 2011. Case series of 226 gamma-hydroxybutyrate-associated deaths: Lethal toxicity and trauma. American Journal of Emergency Medicine 29: 319–332.
   Google Scholar